medigraphic.com
ISSN 1405-1699 (Print)
Órgano Oficial del Colegio Mexicano de Alergia, Asma e Inmunología Pediátrica y de la Asociación Latinoamericana de Pediatría

2019, Number 1

<< Back Next >>

Alerg Asma Inmunol Pediatr 2019; 28 (1)

Anaphylaxis management and prevention

Muro CER, Rodríguez GM, Huerta LJG

Language: Spanish
References: 34
Page: 18-25
PDF size: 244.90 Kb.


ABSTRACT

Anaphylaxis is the most serious of allergic diseases, its delay in management significantly increases morbidity and mortality. So timely detection and management becomes a priority. Among the agents associated with anaphylaxis we find food, medicines, latex, and sting by hymenoptera. Anaphylaxis can affect any organ or system, giving rise to clinical manifestations so wide that they can make the diagnosis difficult. Initial management should be based on the pediatric evaluation triangle (ABCD) and the timely application of intramuscular adrenaline.


REFERENCES

  1. Bellanti J. Immunology. Vol. 6. New York: Springer Science & Business Media; 2013.

  2. Soetens FM. Anaphylaxis during anaesthesia: diagnosis and treatment. Acta Anaesthesiol Belg. 2004; 55 (3): 229-237.

  3. Medina-Hernández A, Huerta-Hernández RE, Góngora-Meléndez MA, Domínguez-Silva MG, Mendoza-Hernández DA, Romero-Tapia S et al. Perfil clínico-epidemiológico de pacientes con sospecha de alergia alimentaria en México. Estudio Mexipreval. Revista Alergia México. 2015; 62 (1): 28-40.

  4. Leung DY, Szefler SJ, Akdis CA, Bonilla FA, Sampson H. Pediatric allergy: principles and practice. Elsevier Health Sciences; 2015.

  5. Simons FE, Sampson HA. Anaphylaxis epidemic: fact or fiction? J Allergy Clin Immunol. 2008; 122 (6): 1166-1168.

  6. Clark S, Camargo CA Jr. Epidemiology of anaphylaxis. Immunol Allergy Clin North Am. 2007; 27 (2): 145-163, v.

  7. Lin RY, Anderson AS, Shah SN, Nurruzzaman F. Increasing anaphylaxis hospitalizations in the first 2 decades of life: New York State, 1990 -2006. Ann Allergy Asthma Immunol. 2008; 101 (4): 387-393.

  8. Méndez de Inocencio JI, Huerta-López JG, Bellanti JA, Ovilla-Martínez R, Escobar-Gutiérrez A. Alergia: enfermedad multisistémica. Fundamentos básicos y clínicos. México: Editorial Médica Panamericana; 2008. Capítulo: 7, pp. 95-98.

  9. Fuzak JK, Trainor J. Comparison of the incidence, etiology, and management of anaphylaxis over time. Pediatr Emerg Care. 2013; 29 (2): 131-135.

  10. Muraro A, Lemanske RF Jr, Castells M, Torres MJ, Khan D, Simon HU et al. Precision medicine in allergic disease-food allergy, drug allergy, and anaphylaxis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology. Allergy. 2017; 72 (7): 1006-1021.

  11. Anaphylaxis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. Allergy.

  12. Sampson HA, Muñoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A et al. Second symposium on the definition and management of anaphylaxis: summary report--second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Ann Emerg Med. 2006; 47 (4): 373-380.

  13. Grabenhenrich LB, Dölle S, Moneret-Vautrin A, Köhli A, Lange L, Spindler T et al. Anaphylaxis in children and adolescents: The European Anaphylaxis Registry. J Allergy Clin Immunol. 2016; 137 (4): 1128-1137.e1.

  14. Juliá-Benito JC, Sánchez-Salguero CA, Alvarado-Izquierdo MI, Álvarez-Caro F, Arroabarren-Alemán E, Capataz-Ledesma M et al. Manual de anafilaxia pediátrica. Sociedad Española de Inmunología Clínica, Alergología y Asma Pediátrica; 2017. Disponible en: http://www.seicap.es/manual-de-anafilaxia-pedi%C3%A1trica_44775.pdf

  15. Rodríguez-González M, Mendoza-Hernández DA, Pedroza-Meléndez A, Orozco-Martínez MS. Características clínicas de pacientes pediátricos con alergia a látex. Alerg Asma Inmunol Pediatr. 2017; 26 (2): 41-44.

  16. Burks AW, Jones SM, Boyce JA, Sicherer SH, Wood RA, Assa’ad A, Sampson HA. NIAID-sponsored 2010 guidelines for managing food allergy: applications in the pediatric population. Pediatrics. 2011; 128 (5): 955-965.

  17. Farbman KS, Michelson KA. Anaphylaxis in children. Curr Opin Pediatr. 2016; 28 (3): 294-297.

  18. Kemp AM, Kemp SF. Pharmacotherapy in refractory anaphylaxis: when intramuscular epinephrine fails. Curr Opin Allergy Clin Immunol. 2014; 14 (4): 371-378.

  19. Campbell RL, Hagan JB, Manivannan V, Decker WW, Kanthala AR, Bellolio MF et al. Evaluation of national institute of allergy and infectious diseases/food allergy and anaphylaxis network criteria for the diagnosis of anaphylaxis in emergency department patients. J Allergy Clin Immunol. 2012; 129 (3): 748-752.

  20. Webb LM, Lieberman P. Anaphylaxis: a review of 601 cases. Ann Allergy Asthma Immunol. 2006; 97 (1): 39-43.

  21. Castells MC, Horan RF, Sheffer AL. Exercise-induced anaphylaxis. Curr Allergy Asthma Rep. 2003; 3 (1): 15-21.

  22. Ditto AM, Harris KE, Krasnick J, Miller MA, Patterson R. Idiopathic anaphylaxis: a series of 335 cases. Ann Allergy Asthma Immunol. 1996; 77 (4): 285-291.

  23. Lockey RF, Benedict LM, Turkeltaub PC, Bukantz SC. Fatalities from immunotherapy (IT) and skin testing (ST). J Allergy Clin Immunol. 1987; 79 (4): 660-677.

  24. Vadas P, Perelman B, Liss G. Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis. J Allergy Clin Immunol. 2013; 131 (1): 144-149.

  25. Gill P, Jindal NL, Jagdis A, Vadas P. Platelets in the immune response: Revisiting platelet-activating factor in anaphylaxis. J Allergy Clin Immunol. 2015; 135 (6): 1424-1432.

  26. Simons FE, Ardusso LR, Bilò MB, El-Gamal YM, Ledford DK, Ring J et al. World allergy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J. 2011; 4 (2): 13-37.

  27. Pumphrey R. Anaphylaxis: can we tell who is at risk of a fatal reaction? Curr Opin Allergy Clin Immunol. 2004; 4 (4): 285-290.

  28. Echeverría-Zudaire LA, del Olmo de la Lama MR, Santana-Rodríguez C. Anafilaxia en pediatría. Protoc Diagn Ter Pediatr. 2013; 1: 63-80.

  29. Simons FE, Sampson HA. Anaphylaxis: Unique aspects of clinical diagnosis and management in infants (birth to age 2 years). J Allergy Clin Immunol. 2015; 135 (5): 1125-1131.

  30. Simons FE, Roberts JR, Gu X, Simons KJ. Epinephrine absorption in children with a history of anaphylaxis. J Allergy Clin Immunol. 1998; 101 (1 Pt 1): 33-37.

  31. Muraro A, Roberts G, Clark A, Eigenmann PA, Halken S, Lack G et al. The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology. Allergy. 2007; 62 (8): 857-871.

  32. Muraro A, Roberts G, Worm M, Bilò MB, Brockow K, Fernández Rivas M et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014; 69 (8): 1026-1045.

  33. Lee S, Bellolio MF, Hess EP, Campbell RL. Predictors of biphasic reactions in the emergency department for patients with anaphylaxis. J Allergy Clin Immunol Pract. 2014; 2 (3): 281-287.

  34. Campbell RL, Li JT, Nicklas RA, Sadosty AT; Members of the Joint Task Force; Practice Parameter Workgroup. Emergency department diagnosis and treatment of anaphylaxis: a practice parameter. Ann Allergy Asthma Immunol. 2014; 113 (6): 599-608.




2020     |     www.medigraphic.com